Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Bashar, Matti"'
Publikováno v:
Clinical Genitourinary Cancer. 20:e114-e125
Objectives To systematically evaluates the evidence on ethnic differences in age-adjusted reference values of PSA. Materials and Methods In concordance with the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement, a r
Autor:
Bashar Matti, Kamran Zargar-Shoshtari
Publikováno v:
International Journal of Urology. 28:578-583
OBJECTIVE To establish age-adjusted reference values for prostate-specific antigen in an ethnically diverse population. METHODS Between 2009 and 2017, data were collected from all men aged 40-79 years, who had a prostate-specific antigen test in the
Publikováno v:
ANZ journal of surgeryReferences. 91(12)
BACKGROUND Prostate cancer (Pca) is the most frequently diagnosed cancer in New Zealand (NZ) men and the third leading cause of cancer deaths. Temporal changes in Pca incidence and mortality have not been reported despite changes in the Pca landscape
Publikováno v:
The ProstateREFERENCES. 81(16)
BACKGROUND Positive surgical margins (PSM) after radical prostatectomy (RP) have been associated with increased risk of biochemical recurrence (BCR). This is heavily influenced by other clinicopathological factors. This study aims to assess the impac
Publikováno v:
The New Zealand medical journal. 133(1523)
Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health profes
Publikováno v:
BJU internationalReferences. 128
OBJECTIVES To investigate the presence of ethnic and socio-economic disparities in prostate cancer (PCa) screening and identify its impact on cancer outcomes. MATERIALS AND METHODS From January 2008 to December 2017, all men in the Northern region of
Autor:
Kamran Zargar-Shoshtari, Bashar Matti
Publikováno v:
Urologic oncology. 38(5)
Background Prostate specific antigen (PSA) utilization in population-based prostate cancer (CaP) screening, has been a controversial area for decades. Current recommendation in our region is for an opportunistic approach to screening, with estimated
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Prostate Specific Antigen (PSA) is the most commonly utilised serum marker for Prostate cancer (Pca) screening and monitoring. However, the validity of PSA as a screenin...
Autor:
Kamran Zargar-Shoshtari, Bashar Matti
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:367.e19-367.e26
Prostate cancer represents a significant health burden on New Zealand men. There are increasing concerns regarding inequities in prostate cancer morbidity and mortality among the different ethnic groups in New Zealand. This study aims to assess ethni
Autor:
Bashar, Matti, Ruben, Cohen-Hallaleh
Publikováno v:
The New Zealand medical journal. 129(1441)
The last few years have witnessed numerous publications addressing the management of thyroid nodules and differentiated thyroid cancers. The purpose of this review is to provide a simplified summary of the newly released guidelines by the American Th